FERMT2 is a high‐risk gene for AD (Karch & Goate, 2015), and epidemiological data show that it is stage‐dependently associated with brain amyloidosis, and most significant in MCI (Apostolova et al., 2018). The gene discussed is FERMT2; the disease is Alzheimer disease.